{
  "id": 6452331,
  "title": "Iron Path Capital’s VION Biosciences closes acquisition of Prolytix",
  "url": "https://urgent.news/2026/09/09/iron-path-capitals-vion-biosciences-closes-acquisition-of-prolytix",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-09T18:16:55.000Z",
  "source": {
    "name": "PE Hub",
    "slug": "pe-hub",
    "url": "https://www.pehub.com/iron-path-capitals-vion-biosciences-closes-acquisition-of-prolytix/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Prolytix provides regulated bioanalytical and CMC services, research reagents, and custom sample collection products to biopharma and diagnostics customers. The post Iron Path Capital’s VION Biosciences closes acquisition of Prolytix appeared first on PE Hub .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}